Incidence of respiratory syncytial virus infection in children with congenital heart disease undergoing immunoprophylaxis with palivizumab in Pará state, north region of Brazil

Abstract Background Palivizumab prophylaxis for the human respiratory syncytial virus (HRSV) has been reported to reduce the risk of hospital admissions related to HRSV in children with congenital heart disease (CHD). These children are at high risk of developing severe lower respiratory tract infec...

Descrición completa

Detalles Bibliográficos

Principais autores:	Roseane Porfírio de Souza, Andre Luis Ribeiro Ribeiro, Sílvio Augusto Fernandes de Menezes, Luiz Fernando Almeida Machado
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2019-08-01
Series:	BMC Pediatrics
Assuntos:	Respiratory syncytial virus Immunization Palivizumab Respiratory tract infections
Acceso en liña:	http://link.springer.com/article/10.1186/s12887-019-1681-6
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!